Insight
Navigating Clinical Complexity with Confidence
Published in Cytometry Part B: Clinical Cytometry
In clinical flow cytometry, real-world scenarios often demand flexibility. The latest manuscript by Christopher Groves and co-authors, "Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories", provides essential guidance for laboratories facing unique patient needs.
This work addresses a critical gap in current standards, offering practical recommendations beyond CLSI H62 for temporary, case-specific assay modifications. It emphasizes:
- Preserving assay integrity while adapting to clinical demands
- Evaluating impact on fluorescence compensation, antibody binding, and sensitivity
- Safeguarding performance without permanent protocol changes
These best practices empower labs to maintain diagnostic excellence while responding to complex clinical situations—ultimately optimizing patient care.
Download Document
Related Insights
Reproducibility Challenges in an era of Massive Data
Presented at the MCBIOS & MAQC 2021 Joint Conference
A Verified Genomic Reference Sample for Assessing Performance of Cancer Panels Detecting Small Variants of Low Allele Frequency
Presented at the MCBIOS & MAQC 2021 Joint Conference
Unexpected Impacts to Library Complexity After DNA and RNA Library Preparation in Illumina Next Generation Sequencing
Presented at the MCBIOS & MAQC 2021 Joint Conference
Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy
Gene expression and analysis for detection of 38 Immune Landscape Signatures
Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials
Genomic technologies that empower and enhance immuno-oncology trials
Laboratory Solutions for Hepatitis B (HBV) Clinical Trials
Insight brief by Joseph Sebastian, Ph.D., Scientific Advisor, Infectious & Liver Diseases
Enabling blood sample prep for single cell sequencing in clinical research
The Role of Genomics in Clinical Trials with Patrick Hurban
I-O clinical development podcast series
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
Evaluating and Implementing SARS-CoV-2 PCR Tests for Diagnostic and Clinical Trial Use
AAPS 2020 COVID-19 Workshop: Current Pharmaceutical Developments for Cures and Prevention
